Abstract
Efficacy and safety of nucleoside reverse transcriptase inhibitor-sparing salvage therapy for multidrug-resistant HIV-1 infection based on new-class and new-generation antiretrovirals
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have